Clinical Trial Update: 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection [Phase 1, Phase 2]

View source ↗

Summary

Open-label phase 1/2 trial update of PRTX-100 in prior rheumatoid arthritis participants with sera collection; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PRTX-100

Snippet

Sponsor: Protalex, Inc. | Conditions: Arthritis, Rheumatoid | Phase 1, Phase 2 | Status: COMPLETED